*Corresponding author:
JunJun Yeh, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi,Chia Nan University of Pharmacy and Science, TaiwanReceived:May 28, 2018; Published:June 08, 2018
DOI: 10.26717/BJSTR.2018.05.001187
To view the Full Article Peer-reviewed Article PDF
Asthma-chronic obstructive pulmonary syndrome (ACOS) is a disorder sharing the components of the asthma and COPD. The ACOS considered as a system inflammation disease. The cytokines such as interleukin-6 (IL-6) [1] and interleukin -10 (IL-10) associated with ACOS [2]. The IL-6 enhancing the inflammation of lung and IL-10 attenuate the inflammation of lung [3,4].
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China